Sonova (OTCMKTS:SONVY) Share Price Crosses Above 50 Day Moving Average – Should You Sell?

Sonova Holding (OTCMKTS:SONVYGet Free Report)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $48.45 and traded as high as $49.36. Sonova shares last traded at $48.32, with a volume of 14,051 shares changing hands.

Analysts Set New Price Targets

SONVY has been the subject of several recent research reports. BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Citigroup restated a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Finally, Jefferies Financial Group lowered Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold”.

View Our Latest Analysis on Sonova

Sonova Price Performance

The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51. The business has a 50-day simple moving average of $48.45 and a 200-day simple moving average of $49.97.

About Sonova

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Featured Articles

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.